Nasdaq

Dr. Reddy's Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Monthly Prescribing Reference

Perrigo Gets FDA Approval for Over-the-Counter Diclofenac Topical Gel

Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist ...
Nasdaq

Dr. Reddy's Announces Launch Of OTC Diclofenac Sodium Topical Gel 1%

(RTTNews) - Dr. Reddy's Laboratories Ltd. (DRREDDY, RDY), on Wednesday, announced the launch of over-the-counter or OTC Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren Arthritis ...
Healio

FDA approves Voltaren Arthritis Pain for nonprescription, OTC use

The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously ...
Monthly Prescribing Reference

Diclofenac Sodium 1% Gel Minimizes Drug-Drug Interaction-Related Adverse Events

HONOLULU, HI—Minimal systemic distribution of topical diclofenac sodium gel resulted in a lower incidence of major or moderate drug-drug interactions associated with oral diclofenac and reduced the ...
The Financial Express

Aleor Dermaceuticals Limited receives USFDA final approval for Diclofenac Sodium Topical Gel

Diclofenac Sodium Topical Gel, 3% is indicated for the topical treatment of actinic keratoses. (File) Alembic Pharmaceuticals Limited (Alembic) on Friday announced that its wholly owned subsidiary, ...
Business Wire

Amneal & PL Developments Launch Store Brand Program of Over-the-Counter (“OTC”) Diclofenac Sodium Topical Gel, 1%

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand ...